Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients

NCT00683124 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

291

Enrollment

OTHER

Sponsor class

Conditions

Marfan Syndrome

Interventions

DRUG: Losartan and nebivolol
DRUG: Losartan
DRUG: Nebivolol

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Collaborators

[object Object]
[object Object]